ADC Therapeutics develops proprietary Antibody Drug Conjugates (ADCs) for the treatment of both solid and hematological cancers.

For virus development and production, it is important to know the virus concentration at different stages of the process, to optimize the clone used as well as the production yields.

Bridging the gap from discovery to verification and validation requires high-performing instruments and software as well as competency in mass spec-based biomarker discovery and method development for biomarker verification.

Identifying and quantifying microplastics in wastewater, sediment and fauna.

Measurement of immunosuppressant drugs is essential during organ transplantation. Under-dosing can lead to organ rejection, while over-dosing can cause serious toxicity.

The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.

This paper describes how robots and automation represent the future of mining, by taking many challenges out of the equation. Lower commodity prices, weaker demand, environmental regulations, lower ore grades, higher running costs are some of the main challenges that the mining industry has to deal with every day.

Download this free white paper from Protein Simple to learn about the differences between MFI and how MFI provides crucial information about your protein therapeutic.

The accuracy and completeness of data is crucial for safe product development and to prevent serious implications regarding human health.

We present a new simplicity-focused analytics methodology, called Sorcerer Score™ that allows low-abundance, modified peptides (LAMPs) to be rigorously identified within a hypothesis-driven framework based on high-accuracy precursor and fragment mass data. Accurate peptide ID is fundamental to accurate protein quantitation and post-translational modification (PTM) analysis.